S&CO Inc’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.9M | Hold |
358,167
| – | – | 0.83% | 31 |
|
|
2025
Q1 | $11.1M | Buy |
358,167
+5
| +0% | +$156 | 0.75% | 34 |
|
|
2024
Q4 | $9.14M | Sell |
358,162
-4,323
| -1% | -$110K | 0.62% | 43 |
|
|
2024
Q3 | $10.3M | Buy |
362,485
+4,220
| +1% | +$119K | 0.67% | 38 |
|
|
2024
Q2 | $9.45M | Buy |
358,265
+17,210
| +5% | +$454K | 0.66% | 38 |
|
|
2024
Q1 | $10.4M | Buy |
341,055
+8,945
| +3% | +$272K | 0.73% | 35 |
|
|
2023
Q4 | $9.33M | Buy |
332,110
+78,500
| +31% | +$2.2M | 0.72% | 34 |
|
|
2023
Q3 | $6.88M | Buy |
253,610
+29,390
| +13% | +$798K | 0.57% | 42 |
|
|
2023
Q2 | $6.89M | Buy |
224,220
+71,290
| +47% | +$2.19M | 0.56% | 41 |
|
|
2023
Q1 | $5.51M | Sell |
152,930
-6,985
| -4% | -$252K | 0.47% | 47 |
|
|
2022
Q4 | $6.32M | Hold |
159,915
| – | – | 0.55% | 42 |
|
|
2022
Q3 | $6.43M | Hold |
159,915
| – | – | 0.58% | 38 |
|
|
2022
Q2 | $6.72M | Buy |
159,915
+20
| +0% | +$841 | 0.57% | 39 |
|
|
2022
Q1 | $6.23M | Buy |
159,895
+14,660
| +10% | +$571K | 0.44% | 48 |
|
|
2021
Q4 | $5.79M | Buy |
145,235
+52,385
| +56% | +$2.09M | 0.41% | 49 |
|
|
2021
Q3 | $3.36M | Buy |
92,850
+31,590
| +52% | +$1.14M | 0.26% | 73 |
|
|
2021
Q2 | $2.51M | Buy |
61,260
+2,520
| +4% | +$103K | 0.2% | 91 |
|
|
2021
Q1 | $2.56M | Buy |
58,740
+1,100
| +2% | +$48K | 0.22% | 81 |
|
|
2020
Q4 | $2.89M | Buy |
57,640
+26,490
| +85% | +$1.33M | 0.26% | 74 |
|
|
2020
Q3 | $1.31M | Buy |
+31,150
| New | +$1.31M | 0.13% | 100 |
|